Travere Therapeutics (TVTX) Capital Expenditures (2013 - 2025)

Travere Therapeutics' (TVTX) quarterly Capital Expenditures came in at $140000.0 in Q3 2025, up 70.73% on a QoQ basis from $82000.0 in Q2 2024.

Travere Therapeutics (TVTX) Capital Expenditures (2013 - 2025) Analysis & Trends

Travere Therapeutics (TVTX) has 13 years of Capital Expenditures data on file, last reported at $140000.0 in Q3 2025.

Quarterly Capital Expenditures changed N/A year-over-year to $140000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $222000.0 (up 107.48% YoY) and the FY2023 annual result came in at $668000.0, up 249.74% from the prior year.
Capital Expenditures rose to $140000.0 in Q3 2025, from $82000.0 in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $4.5 million in Q1 2021 to a low of $3000.0 in Q2 2023.
A 5-year average of $441571.4 and a median of $92500.0 in 2021 frame the typical range for Capital Expenditures.
Annual changes were most pronounced in 2022 — Capital Expenditures plunged 97.09% — and 2024, when it soared 2633.33%.
Tracing TVTX's Capital Expenditures over 5 years: stood at $154000.0 in 2021, then sank by 80.52% to $30000.0 in 2022, then fell by 16.67% to $25000.0 in 2023, then surged by 228.0% to $82000.0 in 2024, then soared by 70.73% to $140000.0 in 2025.
The last three Capital Expenditures figures came in at $140000.0 (Q3 2025), $82000.0 (Q2 2024), and $25000.0 (Q4 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	112.20 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	240.20 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	2.29 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	25.02 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	572,662.23
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	251.02 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	34.68 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	6.26 Mn
10	Travere Therapeutics	5.85 Bn	5.85 Bn	162.52 Mn	-

Download Data